• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Heart Failure: A Companion to Braunwald's Heart Disease

Heart Failure: A Companion to Braunwald's Heart Disease

9780323609876
902,11 zł
766,79 zł Zniżka 135,32 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 766,79 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis

Up-to-date, authoritative and comprehensive, Heart Failure, 4th Edition, provides the clinically relevant information you need to effectively manage and treat patients with this complex cardiovascular problem. This fully revised companion to Braunwalds Heart Disease helps you make the most of new drug therapies such as angiotensin receptor neprilysin inhibitors (ARNIs), recently improved implantable devices, and innovative patient management strategies. Led by internationally recognized heart failure experts Dr. G. Michael Felker and Dr. Douglas Mann, this outstanding reference gives health care providers the knowledge to improve clinical outcomes in heart failure patients.

Szczegóły produktu
Elsevier
62854
9780323609876
9780323609876

Opis

Rok wydania
2019
Numer wydania
4
Oprawa
twarda
Liczba stron
760
Wymiary (mm)
216 x 276
Waga (g)
2310
  • Heart Failure: A Companion to Braunwalds Heart Disease, Fourth Edition

    Contents

    Section 1 Basic Mechanisms of Heart Failure

    1. Molecular Basis for Heart Failure

    2. Cellular Basis for Heart Failure

    3. Cellular Basis for Myocardial Regeneration and Repair

    4. Myocardial Basis for Heart Failure: Role of Cardiac Interstitium

    Section 2 Mechanisms of Disease Progression in Heart Failure

    5. Molecular Signaling Mechanisms of the Renin-Angiotensin System in Heart Failure

    6. Adrenergic Receptor Signaling in Heart Failure

    7. Role of Innate Immunity in Heart Failure

    8. Oxidative Stress in Heart Failure

    9. Natriuretic Peptides in HF

    10. Systolic Dysfunction in Heart Failure

    11. Alterations in Ventricular Function: Diastolic Heart Failure

    12. Alterations in Ventricular Structure: Role of Left Ventricular Remodeling and Reverse Remodeling in Heart Failure

    13. Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure

    14. Alterations in the Peripheral Circulation in Heart Failure

    15. Alterations in Kidney Function Associated with Heart Failure

    16. Alterations in Skeletal Muscle in Heart Failure

    17. Alterations in Cardiac Metabolism

    Section 3 Etiological Basis for Heart Failure

    18. Epidemiology of Heart Failure

    19. Heart Failure as a Consequence of Ischemic Heart Disease

    20. Heart Failure as a Consequence of Dilated Cardiomyopathy

    21. The Restrictive and Infiltrative Cardiomyopathies and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

    22. Cardiac Amyloidosis

    23. Heart Failure as a Consequence of Hypertrophic Cardiomyopathy

    24. Heart Failure as a Consequence of Genetic Cardiomyopathy

    25. Heart Failure as a Consequence of Hypertension

    26. Heart Failure as a Consequence of Valvular Heart Disease

    27. Heart Failure as a Consequence of Congenital Heart Disease

    28. Heart Failure as a Consequence of Viral and Nonviral Myocarditis

    29. Heart Failure in the Developing World

    30. Heart Failure and Human Immunodeficiency Virus

    Section 4 Clinical Assessment of Heart Failure

    31. Clinical Evaluation of Heart Failure

    32. Cardiac Imaging in Heart Failure

    33. Biomarkers and Precision Medicine in Heart Failure

    34. Hemodynamics in Heart Failure

    Section 5 Therapy for Heart Failure

    35. Disease Prevention in Heart Failure

    36. Management of Acute Decompensated Heart Failure

    Guidelines

    37. Contemporary Medical Therapy for Heart Failure Patients with Reduced Ejection Fraction

    Guidelines: Management of Heart Failure with a Reduced Ejection Fraction

    38. Management of Arrhythmias and Device Therapy in Heart Failure

    Guidelines

    39. Treatment of Heart Failure with Preserved Ejection Fraction

    Guidelines

    40. Management of Heart Failure in Special Populations: Older Patients, Women, and Racial/Ethnic Minority Groups

    41. Gene and Stem-Cell Based Therapies in Heart Failure

    42. Neuromodulation in Heart Failure

    43. Pulmonary Hypertension

    44. Cardiac Transplantation

    45. Circulatory Assist Devices in Heart Failure

    46. Cardio-Oncology and Heart Failure

    47. Disease Management and Telemedicine in Heart Failure

    48. Management of Comorbidities in Heart Failure

    49. Quality and Outcomes in Heart Failure

    50. Decision Making and Palliative Care in Advanced Heart Failure

Komentarze (0)